KRT17 and adrenal cortex carcinoma: The expression of KRT17 in some stages was higher than that in normal tissues (Supplementary Figure S1D), while in BRCA, KICH and KIRC, the expression of KRT17 in each stage was lower than that in normal tissues, and the difference was statistically significant (p < 0.05) (Supplementary Figure S1E); no significant differences were found in other tumors (some of which did not have available data for matched normal tissue comparison; these included ACC, DLBC, MESO, UVM, OV, TGCT, and UCS) (Supplementary Figures S1F,H).